Jonathan Miksch Selected Research

Radiotherapy

11/2023	[Opportunities for prostate-specific membrane antigen hybrid imaging in prostate cancer].
1/2022	Metastasis-Free Survival and Patterns of Distant Metastatic Disease After Prostate-Specific Membrane Antigen Positron Emission Tomography (PSMA-PET)-Guided Salvage Radiation Therapy in Recurrent or Persistent Prostate Cancer After Prostatectomy.
1/2021	Changes of Radiation Treatment Concept Based on 68Ga-PSMA-11-PET/CT in Early PSA-Recurrences After Radical Prostatectomy.
1/2020	Interobserver variability, detection rate, and lesion patterns of 68Ga-PSMA-11-PET/CT in early-stage biochemical recurrence of prostate cancer after radical prostatectomy.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Jonathan Miksch Research Topics

Disease

7	Prostatic Neoplasms (Prostate Cancer) 01/2024 - 01/2020
2	Neoplasms (Cancer) 11/2023 - 10/2022
1	Lymphatic Metastasis 01/2023
1	Neoplasm Metastasis (Metastasis) 01/2022

Drug/Important Bio-Agent (IBA)

4	AntigensIBA 01/2024 - 01/2022
1	Prostate-Specific Antigen (Semenogelase)IBA 01/2023
1	AndrogensIBA 01/2023
1	LigandsIBA 10/2022
1	PSMA-617IBA 10/2022
1	PSMA-11IBA 10/2022
1	177Lu-PSMA-617IBA 10/2022

Therapy/Procedure

4	Radiotherapy 11/2023 - 01/2020
3	Prostatectomy (Retropubic Prostatectomy) 01/2022 - 01/2020
2	Therapeutics 11/2023 - 01/2023
1	Aftercare (After-Treatment) 10/2022
1	Castration 10/2022